Bas Oldenburg

Full Professor

Strategic program(s):

Contact

boldenbu@umcutrecht.nl

Pure profile

Research groups

Inflammatory bowel diseases

Research aim

Our research is focused on the elucidation of the pathogenesis of Inflammatory bowel diseases (IBD), personalized medicine and on a severe complication of IBD: colitis-associated colorectal carcinoma.

Go to group

Molecular and cellular host-microbiota interactions

Research aim

Our research aims to unravel how the products from pathogenic and beneficial bacterial species within the intestinal microbiota contribute to human health and disease.

Go to group

Tissue immunology

Research aim

Our mission is to comprehensively understand, monitor, and target immune-mediated inflammatory diseases such as IBD, AD and systemic autoimmune diseases. We aim to unravel (tissue) immune dysregulation and induce long-lasting disease modification.

Go to group

Recent publications

All publications

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova, Noël M M Dautzenberg, Mark Schuiveling, Rik J Verheijden, Fiona D M van Schaik, Bas Oldenburg, Stefan Nierkens, Karijn P M Suijkerbuijk, Femke van Wijk,
Communications medicine, 2025, vol. 5, p.1-14

Mucosal Kinase Activity and Inflammatory Profiles in Inflammatory Bowel Disease, and in Relation with Tofacitinib Response Eelco C Brand, Britt Roosenboom, Lisanne Lutter, Bea Malvar Fernandez, Savithri Rangarajan, Elly Van Koolwijk, Sara Van Gennep, Geert R D'Haens, Ellen G Van Lochem, Carmen S Horjus Talabur Horje, Kris A Reedquist, Femke Van Wijk, Bas Oldenburg
Journal of Crohn's & Colitis, 2025, vol. 19

Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease Marie Meima, Joost Westerhout, Marjolein Meijerink, Sabina Bijlsma, Fiona van Schaik, Bas Oldenburg, Geert Houben
Inflammatory bowel diseases, 2025, vol. 31, p.3051-3059

Reply to 'Critical appraisal of the HELIOS study on surveillance in IBD patients' Maarten Te Groen, Anouk M Wijnands, Bas Oldenburg, Frank Hoentjen
Gut, 2025, vol. 74, p.1932-1933

Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease Dorien Oomkens, Zlatan Mujagic, Annemarie de Vries, Andrea van der Meulen-de Jong, Tessa Straatmijer, Mark Löwenberg, Sander van der Marel, Rachel West, Alexander Bodelier, Fiona van Schaik, Marijn Visschedijk, Marjolijn Duijvestein, on Crohn Initiative on Crohn, Rinse Weersma, Janneke van der Woude, Michael van der Voorn, Philip Voorneveld, Pieter Stokkers, Nidhi Srivastava, Jael Smid, Maurice Russel, Tessa Römkens, Cyriel Ponsioen, Marieke Pierik, Bas Oldenburg, Liekele Oostenbrug, Loes Nissen, Peter Mensink, Wout Mares, Nofel Mahmmod, Jeroen Maljaars, Desiree Leemreis, Bindia Jharap, Dirk de Jong, Jeroen Jansen, Carmen Horjus, Marcel Groenen, Noortje Festen, Willemijn van Dop, Geert D’Haens, Gerard Dijkstra, Gerd Bouma, Nanne de Boer, Ad van Bodegraven
Digestive Diseases and Sciences, 2025, vol. 70, p.2786–2793

The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies H M Smits, E M Delemarre, A Pandit, A H Schoneveld, B Oldenburg, F van Wijk, S Nierkens, J Drylewicz
Scientific Reports, 2025, vol. 15